Skip to main content
SpringerLink
Log in

Heart, Coronary Arteries, Aorta and Great Vessels, Arteries and Veins, Microcirculation

  • Chapter
  • First Online:
ALERT • Adverse Late Effects of Cancer Treatment

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 1512 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ACEI:

Angiotensin-converting enzyme inhibitors

AV:

Atrioventricular

NT-proBNP:

Brain natriuretic peptide and N-terminal fragment

CAC:

Coronary artery calcification

EBCTCG:

Early breast cancer trialists’ collaborative group

EGFR:

Epidermal growth factor receptor

HR:

Hazard ratios

HER2:

Human epidermal growth factor receptor 2

LAD:

Left anterior descending artery

LCX:

Left circumflex artery

LSS:

Life span study

MR:

Magnetic resonance

NTCP:

Normal tissue complication probability

PCI:

Percutaneous coronary intervention

PDA:

Posterior descending artery

RT:

Radiation treatment

RCA:

Right coronary artery

RMA:

Right marginal artery

SE:

Standard error

SIR:

Standardized incidence ratios

SEER:

Surveillance, epidemiology and end-results cancer registries

VEGF:

Vascular endothelial growth factor

References

  • Adams MJ, Lipshultz SE (2005) Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention. Pediatr Blood Cancer 44(7):600–606

    PubMed  Google Scholar 

  • Adams MJ, Lipshultz SE, Schwartz C et al (2003) Radiation-associated cardiovascular disease: manifestations and management. Semin Radiat Oncol 13(3):346–356

    PubMed  Google Scholar 

  • Adams MJ, Lipsitz SR, Colan SD et al (2004) Cardiovascular status in long-term survivors of Hodgkin’s disease treated with chest radiotherapy. J Clin Oncol 22(15):3139–3148

    PubMed  Google Scholar 

  • AGIR (2010) Circulatory Disease Risk. Report of the Independent Advisory Group on Ionising Radiation. Doc. HPA, RCE-16. The Health Protection Agency, Chilton, UK

    Google Scholar 

  • Akhtar SS, Salim KP, Bano ZA (1993) Symptomatic cardiotoxicity with high-dose 5-fluorouracil infusion: a prospective study. Oncology 50(6):441–444

    PubMed  CAS  Google Scholar 

  • Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 23(5):469–480

    PubMed  CAS  Google Scholar 

  • Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120(16):1640–1645

    PubMed  CAS  Google Scholar 

  • Albini A, Pennesi G, Donatelli F et al (2010) Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst 102(1):14–25

    PubMed  CAS  PubMed Central  Google Scholar 

  • Aleman BM, van den Belt-Dusebout AW, Klokman WJ et al (2003) Long-term cause-specific mortality of patients treated for Hodgkin’s disease. J Clin Oncol 21(18):3431–3439

    PubMed  Google Scholar 

  • Aleman BM, van den Belt-Dusebout AW, De Bruin ML et al (2007) Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109(5):1878–1886

    PubMed  CAS  Google Scholar 

  • Andersen R, Wethal T, Gunther A et al (2010) Relation of coronary artery calcium score to premature coronary artery disease in survivors >15 years of Hodgkin’s lymphoma. Am J Cardiol 105(2):149–152

    PubMed  Google Scholar 

  • Annaloro C, Usardi P, Airaghi L et al (2008) Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant 41(9):797–804

    PubMed  CAS  Google Scholar 

  • Anversa P, Leri A, Rota M et al (2007) Concise review: stem cells, myocardial regeneration, and methodological artifacts. Stem Cells 25(3):589–601

    PubMed  CAS  Google Scholar 

  • Arbuck SG, Strauss H, Rowinsky E et al (1993) A reassessment of cardiac toxicity associated with Taxol. J Natl Cancer Inst Monogr 15:117–130

    PubMed  Google Scholar 

  • Arola OJ, Saraste A, Pulkki K et al (2000) Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 60(7):1789–1792

    PubMed  CAS  Google Scholar 

  • Atallah E, Durand JB, Kantarjian H et al (2007) Congestive heart failure is a rare event in patients receiving imatinib therapy. Blood 110(4):1233–1237

    PubMed  CAS  Google Scholar 

  • Azizi M, Chedid A, Oudard S (2008) Home blood-pressure monitoring in patients receiving sunitinib. N Engl J Med 358(1):95–97

    PubMed  CAS  Google Scholar 

  • Bakx JC, Veldstra MI, van den Hoogen HM et al (2001) Blood pressure and cardiovascular morbidity and mortality in a Dutch population: the Nijmegen cohort study. Prev Med 32(2):142–147

    PubMed  CAS  Google Scholar 

  • Barbey JT, Pezzullo JC, Soignet SL (2003) Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J Clin Oncol 21(19):3609–3615

    PubMed  CAS  Google Scholar 

  • Barry E, Alvarez JA, Scully RE et al (2007) Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opin Pharmacother 8(8):1039–1058

    PubMed  CAS  Google Scholar 

  • Bertog SC, Thambidorai SK, Parakh K et al (2004) Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol 43(8):1445–1452

    PubMed  Google Scholar 

  • Blanco JG, Leisenring WM, Gonzalez-Covarrubias VM et al (2008) Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer. Cancer 112(12):2789–2795

    PubMed  Google Scholar 

  • Boivin JF, Hutchison GB, Lubin JH et al (1992) Coronary artery disease mortality in patients treated for Hodgkin’s disease. Cancer 69(5):1241–1247

    PubMed  CAS  Google Scholar 

  • Bovelli D, Plataniotis G, Roila F (2010) Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO clinical practice guidelines. Ann Oncol 21(Suppl 5):v277–v282

    PubMed  Google Scholar 

  • Bowers DC, McNeil DE, Liu Y et al (2005) Stroke as a late treatment effect of Hodgkin’s disease: a report from the childhood cancer survivor study. J Clin Oncol 23(27):6508–6515

    PubMed  Google Scholar 

  • Bowers DC, Liu Y, Leisenring W et al (2006) Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the childhood cancer survivor study. J Clin Oncol 24(33):5277–5282

    PubMed  Google Scholar 

  • Braverman AC, Antin JH, Plappert MT et al (1991) Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol 9(7):1215–1223

    PubMed  CAS  Google Scholar 

  • Breccia M (2011) Is imatinib-related cardiotoxicity still an open issue? Leuk Res 35(1):34–35

    PubMed  CAS  Google Scholar 

  • Brosius FC III, Waller BF, Roberts WC (1981) Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. Am J Med 70(3):519–530

    PubMed  Google Scholar 

  • Burman C, Kutcher GJ, Emami B et al (1991) Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21(1):123–135

    PubMed  CAS  Google Scholar 

  • Burstein HJ, Elias AD, Rugo HS et al (2008) Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol 26(11):1810–1816

    PubMed  CAS  Google Scholar 

  • Byhardt R, Brace K, Ruckdeschel J et al (1975) Dose and treatment factors in radiation-related pericardial effusion associated with the mantle technique for Hodgkin’s disease. Cancer 35(3):795–802

    PubMed  CAS  Google Scholar 

  • Caplice NM, Doyle B (2005) Vascular progenitor cells: origin and mechanisms of mobilization, differentiation, integration, and vasculogenesis. Stem Cells Dev 14(2):122–139

    PubMed  Google Scholar 

  • Cardinale D, Sandri MT, Martinoni A et al (2000) Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. J Am Coll Cardiol 36(2):517–522

    PubMed  CAS  Google Scholar 

  • Cardinale D, Colombo A, Colombo N (2006a) Acute coronary syndrome induced by oral capecitabine. Can J Cardiol 22(3):251–253

    Google Scholar 

  • Cardinale D, Colombo A, Sandri MT et al (2006b) Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation 114(23):2474–2481

    Google Scholar 

  • Cardinale D, Colombo A, Lamantia G et al (2010) Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol 55(3):213–220

    PubMed  CAS  Google Scholar 

  • Carlson RG, Mayfield WR, Normann S et al (1991) Radiation-associated valvular disease. Chest 99(3):538–545

    PubMed  CAS  Google Scholar 

  • Carr ZA, Land CE, Kleinerman RA et al. (2005) Coronary heart disease after radiotherapy for peptic ulcer disease. Int J Radiat Oncol Biol Phys 61(3):842–850

    Google Scholar 

  • Carmel RJ, Kaplan HS (1976) Mantle irradiation in Hodgkin’s disease. An analysis of technique, tumor eradication, and complications. Cancer 37(6):2813–2825

    PubMed  CAS  Google Scholar 

  • Chaosuwannakit N, D’Agostino R Jr, Hamilton CA et al (2010) Aortic stiffness increases upon receipt of anthracycline chemotherapy. J Clin Oncol 28(1):166–172

    PubMed  CAS  PubMed Central  Google Scholar 

  • Cheitlin MD, Armstrong WF, Aurigemma GP et al (2003) ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography). Circulation 108(9):1146–1162

    PubMed  Google Scholar 

  • Chen MH (2009) Cardiac dysfunction induced by novel targeted anticancer therapy: an emerging issue. Curr Cardiol Rep 11(3):167–174

    PubMed  CAS  Google Scholar 

  • Chen MH, Chuang ML, Bornstein BA et al (1997) Impact of respiratory maneuvers on cardiac volume within left-breast radiation portals. Circulation 96(10):3269–3272

    PubMed  CAS  Google Scholar 

  • Chen MH, Cash EP, Danias PG et al (2002) Respiratory maneuvers decrease irradiated cardiac volume in patients with left-sided breast cancer. J Cardiovasc Magn Reson 4(2):265–271

    PubMed  Google Scholar 

  • Chen MH, Kerkela R, Force T (2008) Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics. Circulation 118(1):84–95

    PubMed  PubMed Central  Google Scholar 

  • Chen MH, Colan SD, Diller L (2011) Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers. Circ Res 108(5):619–628

    PubMed  CAS  Google Scholar 

  • Cheng H, Force T (2010) Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeutics. Circ Res 106(1):21–34

    PubMed  CAS  Google Scholar 

  • Chobanian AV, Bakris GL, Black HR et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206–1252

    PubMed  CAS  Google Scholar 

  • Chowdhury UK, Subramaniam GK, Kumar AS et al (2006) Pericardiectomy for constrictive pericarditis: a clinical, echocardiographic, and hemodynamic evaluation of two surgical techniques. Ann Thorac Surg 81(2):522–529

    PubMed  Google Scholar 

  • Chu TF, Rupnick MA, Kerkela R et al (2007) Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet 370(9604):2011–2019

    PubMed  CAS  PubMed Central  Google Scholar 

  • Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106

    PubMed  CAS  Google Scholar 

  • Cobleigh MA, Langmuir VK, Sledge GW et al (2003) A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer. Semin Oncol 30(5 Suppl 16):117–124

    PubMed  CAS  Google Scholar 

  • Cohn KE, Stewart JR, Fajardo LF et al (1967) Heart disease following radiation. Medicine (Baltimore) 46(3):281–298

    CAS  Google Scholar 

  • Coronary Artery Surgery Study (CASS) (1983) A randomized trial of coronary artery bypass surgery. Survival data. Circulation 68(5):939–950

    Google Scholar 

  • Correa CR, Litt HI, Hwang WT et al (2007) Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol 25(21):3031–3037

    PubMed  Google Scholar 

  • Cosset JM, Henry-Amar M, Girinski T et al (1988) Late toxicity of radiotherapy in Hodgkin’s disease. The role of fraction size. Acta Oncol 27(2):123–129

    PubMed  CAS  Google Scholar 

  • Cosset JM, Henry-Amar M, Meerwaldt JH (1991) Long-term toxicity of early stages of Hodgkin’s disease therapy: the EORTC experience. EORTC lymphoma cooperative group. Ann Oncol 2(Suppl 2):77–82

    PubMed  Google Scholar 

  • Cowen D, Gonzague-Casabianca L, Brenot-Rossi I et al. (1998) Thallium-201 perfusion scintigraphy in the evaluation of late myocardial damage in left-side breast cancer treated with adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 41(4):809–815

    Google Scholar 

  • Crone SA, Zhao YY, Fan L et al (2002) ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med 8(5):459–465

    PubMed  CAS  Google Scholar 

  • Cuzick J, Stewart HJ, Peto R et al (1988) Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Recent Results Cancer Res 111:108–129

    PubMed  CAS  Google Scholar 

  • Cuzick J, Stewart H, Rutqvist L et al (1994) Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12(3):447–453

    PubMed  CAS  Google Scholar 

  • Czaykowski PM, Moore MJ, Tannock IF (1998) High risk of vascular events in patients with urothelial transitional cell carcinoma treated with cisplatin based chemotherapy. J Urol 160(6 Pt 1):2021–2024

    PubMed  CAS  Google Scholar 

  • Darby S, McGale P, Peto R et al (2003) Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90,000 Swedish women. BMJ 326(7383):256–257

    PubMed  PubMed Central  Google Scholar 

  • Darby SC, McGale P, Taylor CW et al (2005) Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6(8):557–565

    PubMed  Google Scholar 

  • Darby SC, Cutter DJ, Boerma M et al (2010) Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys 76(3):656–665

    PubMed  Google Scholar 

  • De Angelis A, Piegari E, Cappetta D et al (2010) Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation 121(2):276–292

    PubMed  PubMed Central  Google Scholar 

  • De Bruin ML, Dorresteijn LD (2009) van’t Veer MB et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst 101(13):928–937

    PubMed  Google Scholar 

  • De Forni M, Malet-Martino MC, Jaillais P et al (1992) Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study. J Clin Oncol 10(11):1795–1801

    PubMed  Google Scholar 

  • De Haas EC, Oosting SF, Lefrandt JD et al (2010) The metabolic syndrome in cancer survivors. Lancet Oncol 11(2):193–203

    PubMed  Google Scholar 

  • Demetri GD, van Oosterom AT, Garrett CR et al (2006) Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 368(9544):1329–1338

    PubMed  CAS  Google Scholar 

  • Deng S, Wojnowski L (2007) Genotyping the risk of anthracycline-induced cardiotoxicity. Cardiovasc Toxicol 7(2):129–134

    PubMed  CAS  Google Scholar 

  • Di Paolo A, Danesi R, Falcone A et al (2001) Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients. Ann Oncol 12(9):1301–1306

    PubMed  Google Scholar 

  • Doroshow JH, Locker GY, Myers CE (1980) Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. J Clin Invest 65(1):128–135

    PubMed  CAS  PubMed Central  Google Scholar 

  • Dorresteijn LD, Kappelle AC, Boogerd W et al (2002) Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol 20(1):282–288

    PubMed  Google Scholar 

  • Einhorn D, Reaven GM, Cobin RH et al (2003) American college of endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9(3):237–252

    PubMed  Google Scholar 

  • Emami B, Lyman J, Brown A et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21(1):109–122

    PubMed  CAS  Google Scholar 

  • Erickson SL, O’Shea KS, Ghaboosi N et al (1997) ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. Development 124(24):4999–5011

    PubMed  CAS  Google Scholar 

  • Eriksson F, Gagliardi G, Liedberg A et al. (2000) Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model. Radiother Oncol 55(2):153–162

    Google Scholar 

  • Escudier B, Eisen T, Stadler WM et al (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356(2):125–134

    PubMed  CAS  Google Scholar 

  • Evans ES, Prosnitz RG, Yu X et al (2006) Impact of patient-specific factors, irradiated left ventricular volume, and treatment set-up errors on the development of myocardial perfusion defects after radiation therapy for left-sided breast cancer. Int J Radiat Oncol Biol Phys 66(4):1125–1134

    PubMed  Google Scholar 

  • Ewer MS, O’Shaughnessy JA (2007) Cardiac toxicity of trastuzumab-related regimens in HER2-overexpressing breast cancer. Clin Breast Cancer 7(8):600–607

    PubMed  CAS  Google Scholar 

  • Executive Summary of the Third Report of the National cholesterol Education Program (NCEP) Expert Panel on Detection (2001) Evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 285:2486–2497

    Google Scholar 

  • Fahdi IE, Gaddam V, Saucedo JF et al (2004) Bradycardia during therapy for multiple myeloma with thalidomide. Am J Cardiol 93(8):1052–1055

    PubMed  CAS  Google Scholar 

  • Fainaru O, Adini I, Benny O et al (2008) Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability. FASEB J 22(10):3728–3735

    PubMed  CAS  Google Scholar 

  • Fajardo LF, Berthrong M, Anderson RE (2001) Radiation pathology. Oxford University Press, New York

    Google Scholar 

  • Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer (2000): an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 355(9217):1757–1770

    Google Scholar 

  • Floyd JD, Nguyen DT, Lobins RL et al (2005) Cardiotoxicity of cancer therapy. J Clin Oncol 23(30):7685–7696

    PubMed  CAS  Google Scholar 

  • Force T, Krause DS, Van Etten RA (2007) Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition. Nat Rev Cancer 7(5):332–344

    PubMed  CAS  Google Scholar 

  • Francis GS, Wilson Tang WH, Sonnenblick EM (2004) The pathophysiology of heart failure. In: Fuster V, Alexander RW, ‘O’Rourke RA (eds) Hurst’s the heart. MsGraw-Hill, New York, pp 697–792

    Google Scholar 

  • Frickhofen N, Beck FJ, Jung B et al (2002) Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil. Ann Oncol 13(5):797–801

    PubMed  CAS  Google Scholar 

  • Gagliardi G, Lax I, Ottolenghi A et al (1996) Long-term cardiac mortality after radiotherapy of breast cancer—application of the relative seriality model. Br J Radiol 69(825):839–846

    PubMed  CAS  Google Scholar 

  • Gagliardi G, Constine LS, Moiseenko V et al (2010) Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 76(3 Suppl):S77–S85

    PubMed  Google Scholar 

  • Galper SL, Yu JB, Mauch PM et al (2010) Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood 116:2237–2240

    Google Scholar 

  • Gaya AM, Ashford RF (2005) Cardiac complications of radiation therapy. Clin Oncol (R Coll Radiol) 17(3):153–159

    CAS  Google Scholar 

  • Gianni L, Salvatorelli E, Minotti G (2007) Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes. Cardiovasc Toxicol 7(2):67–71

    PubMed  CAS  Google Scholar 

  • Giantris A, Abdurrahman L, Hinkle A et al (1998) Anthracycline-induced cardiotoxicity in children and young adults. Crit Rev Oncol Hematol 27(1):53–68

    PubMed  CAS  Google Scholar 

  • Giordano SH, Kuo YF, Freeman JL et al (2005) Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97(6):419–424

    PubMed  PubMed Central  Google Scholar 

  • Girinsky T, Cordova A, Rey A et al (2000) Thallium-201 scintigraphy is not predictive of late cardiac complications in patients with Hodgkin’s disease treated with mediastinal radiation. Int J Radiat Oncol Biol Phys 48(5):1503–1506

    PubMed  CAS  Google Scholar 

  • Glanzmann C, Huguenin P, Lutolf UM et al (1994) Cardiac lesions after mediastinal irradiation for Hodgkin’s disease. Radiother Oncol 30(1):43–54

    PubMed  CAS  Google Scholar 

  • Glanzmann C, Kaufmann P, Jenni R et al (1998) Cardiac risk after mediastinal irradiation for Hodgkin’s disease. Radiother Oncol 46(1):51–62

    PubMed  CAS  Google Scholar 

  • Goldberg MA, Antin JH, Guinan EC et al (1986) Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood 68(5):1114–1118

    PubMed  CAS  Google Scholar 

  • Goormaghtigh E, Huart P, Praet M et al (1990) Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity. Biophys Chem 35(2–3):247–257

    PubMed  CAS  Google Scholar 

  • Gottdiener JS, Appelbaum FR, Ferrans VJ et al (1981) Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 141(6):758–763

    PubMed  CAS  Google Scholar 

  • Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation 112(17):2735–2752

    PubMed  Google Scholar 

  • Guarneri V, Lenihan DJ, Valero V et al (2006) Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson cancer center experience. J Clin Oncol 24(25):4107–4115

    PubMed  CAS  Google Scholar 

  • Guglin M, Cutro R, Mishkin JD (2008) Trastuzumab-induced cardiomyopathy. J Cardiac Fail 14(5):437–444

    CAS  Google Scholar 

  • Gustavsson A, Eskilsson J, Landberg T et al (1990) Late cardiac effects after mantle radiotherapy in patients with Hodgkin’s disease. Ann Oncol 1(5):355–363

    PubMed  CAS  Google Scholar 

  • Gyenes G, Fornander T, Carlens P et al. (1994) Morbidity of ischemic heart disease in early breast cancer 15–20 years after adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 28(5):1235–1241

    Google Scholar 

  • Gyenes G, Fornander T, Carlens P et al. (1996) Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys 36(4):899–905

    Google Scholar 

  • Haberl R, Becker A, Leber A et al (2001) Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients. J Am Coll Cardiol 37(2):451–457

    PubMed  CAS  Google Scholar 

  • Haider AW, Larson MG, Franklin SS et al (2003) Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham heart study. Ann Intern Med 138(1):10–16

    PubMed  Google Scholar 

  • Halyard MY, Pisansky TM, Dueck AC et al (2009) Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831. J Clin Oncol 27(16):2638–2644

    PubMed  CAS  PubMed Central  Google Scholar 

  • Hampton T (2010) Cancer therapy can be hard on the heart: researchers aim to explain—and avoid—cardiotoxicity. JAMA 303(11):1019–1020

    PubMed  Google Scholar 

  • Hancock SL, Hoppe RT (1996) Long-term complications of treatment and causes of mortality after Hodgkin’s disease. Semin Radiat Oncol 6(3):225–242

    PubMed  Google Scholar 

  • Hancock SL, Donaldson SS, Hoppe RT (1993a) Cardiac disease following treatment of Hodgkin’s disease in children and adolescents. J Clin Oncol 11(7):1208–1215

    Google Scholar 

  • Hancock SL, Tucker MA, Hoppe RT (1993b) Factors affecting late mortality from heart disease after treatment of Hodgkin’s disease. JAMA 270(16):1949–1955

    Google Scholar 

  • Harris EE, Correa C, Hwang WT et al (2006) Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol 24:4100–4106

    Google Scholar 

  • Hatfield A, Owen S, Pilot PR (2007) In reply to ‘cardiotoxicity of the cancer therapeutic agent imatinib mesylate’. Nat Med 13(1):13–16

    PubMed  CAS  Google Scholar 

  • Haugnes HS, Aass N, Fossa SD et al (2007) Components of the metabolic syndrome in long-term survivors of testicular cancer. Ann Oncol 18(2):241–248

    PubMed  CAS  Google Scholar 

  • Haynes JC, Machtay M, Weber RS et al (2002) Relative risk of stroke in head and neck carcinoma patients treated with external cervical irradiation. Laryngoscope 112(10):1883–1887

    PubMed  Google Scholar 

  • Heidenreich PA, Hancock SL, Lee BK et al (2003) Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 42(4):743–749

    PubMed  Google Scholar 

  • Heidenreich PA, Schnittger I, Strauss HW et al (2007) Screening for coronary artery disease after mediastinal irradiation for Hodgkin’s disease. J Clin Oncol 25(1):43–49

    PubMed  Google Scholar 

  • Herman EH, Zhang J, Lipshultz SE et al (1999) Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J Clin Oncol 17(7):2237–2243

    PubMed  CAS  Google Scholar 

  • Herman EH, Zhang J, Rifai N et al (2001) The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity. Cancer Chemother Pharmacol 48(4):297–304

    PubMed  CAS  Google Scholar 

  • Hojris I, Overgaard M, Christensen JJ et al (1999) Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy committee of the Danish breast cancer cooperative group. Lancet 354(9188):1425–1430

    PubMed  CAS  Google Scholar 

  • Hojris I, Sand NP, Andersen J et al. (2000) Myocardial perfusion imaging in breast cancer patients treated with or without post-mastectomy radiotherapy. Radiother Oncol 55(2):163–172

    Google Scholar 

  • Hooning MJ, Botma A, Aleman BM et al (2007) Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 99(5):365–375

    PubMed  Google Scholar 

  • Hoving S, Heeneman S et al (2008) Single-dose and fractionated irradiation promote initiation and progression of artherosclerosis and induce an inflammatory plaque phenotype in Apo(-/-) mice. Int J Radiat Oncol Biol Phys 71(3):848–857

    Google Scholar 

  • Huang SY, Chang CS, Tang JL et al (1998) Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia. Br J Haematol 103(4):1092–1095

    PubMed  CAS  Google Scholar 

  • Hull MC, Morris CG, Pepine CJ et al (2003) Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 290(21):2831–2837

    PubMed  CAS  Google Scholar 

  • Hunt SA, Abraham WT, Chin MH et al (2009) 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American college of cardiology foundation/american heart association task force on practice guidelines: developed in collaboration with the international society for heart and lung transplantation. Circulation 119(14):e391–e479

    PubMed  Google Scholar 

  • Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350(23):2335–2342

    PubMed  CAS  Google Scholar 

  • ICRP Report (2012) Early and late effects of radiation in normal tissues and organs: threshold doses for tissue reactions in a radiation protection context (in press) Ref Type: Report http://www.icrp.org/page.asp?id=116

  • Imai K, Takaoka A (2006) Comparing antibody and small-molecule therapies for cancer. Nat Rev Cancer 6(9):714–727

    PubMed  CAS  Google Scholar 

  • Izumiya Y, Shiojima I, Sato K et al (2006) Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 47(5):887–893

    PubMed  CAS  PubMed Central  Google Scholar 

  • Jensen SA, Sorensen JB (2006) Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine. Cancer Chemother Pharmacol 58(4):487–493

    PubMed  CAS  Google Scholar 

  • Johnson DH, Fehrenbacher L, Novotny WF et al (2004) Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 22(11):2184–2191

    PubMed  CAS  Google Scholar 

  • Jones LW, Haykowsky MJ, Swartz JJ et al (2007) Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol 50:1435–1441

    PubMed  Google Scholar 

  • Kabbinavar FF, Schulz J, McCleod M et al (2005) Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol 23(16):3697–3705

    PubMed  CAS  Google Scholar 

  • Kamba T, McDonald DM (2007) Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer 96(12):1788–1795

    PubMed  CAS  PubMed Central  Google Scholar 

  • Kang YJ (2001) Molecular and cellular mechanisms of cardiotoxicity. Environ Health Perspect 109(Suppl 1):27–34

    PubMed  CAS  PubMed Central  Google Scholar 

  • Kannel WB (1996) Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 275(20):1571–1576

    PubMed  CAS  Google Scholar 

  • Kaur A, Yu SS, Lee AJ et al (2003) Thalidomide-induced sinus bradycardia. Ann Pharmacother 37(7–8):1040–1043

    PubMed  Google Scholar 

  • Keefe DL (2001) Anthracycline-induced cardiomyopathy. Semin Oncol 28(4 Suppl 12):2–7

    PubMed  CAS  Google Scholar 

  • Keefe DL, Roistacher N, Pierri MK (1993) Clinical cardiotoxicity of 5-fluorouracil. J Clin Pharmacol 33(11):1060–1070

    PubMed  CAS  Google Scholar 

  • Kerkela R, Grazette L, Yacobi R et al (2006) Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med 12(8):908–916

    PubMed  Google Scholar 

  • Kerkela R, Woulfe KC, Durand JB et al (2009) Sunitinib-induced cardiotoxicity is mediated by off-target inhibition of AMP-activated protein kinase. Clin Transl Sci 2(1):15–25

    PubMed  CAS  PubMed Central  Google Scholar 

  • Khakoo AY, Kassiotis CM, Tannir N et al (2008) Heart failure associated with sunitinib malate: a multitargeted receptor tyrosine kinase inhibitor. Cancer 112(11):2500–2508

    PubMed  CAS  Google Scholar 

  • Kilickap S, Abali H, Celik I (2003) Bevacizumab, bleeding, thrombosis, and warfarin. J Clin Oncol 21(18):3542

    PubMed  Google Scholar 

  • Klocke FJ, Baird MG, Lorell BH et al (2003) ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/ASNC committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). Circulation 108(11):1404–1418

    PubMed  Google Scholar 

  • Kohne CH, Thuss-Patience P, Friedrich M et al (1998) Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity. Br J Cancer 77(6):973–977

    PubMed  CAS  Google Scholar 

  • Korreman SS, Pedersen AN, Aarup LR et al (2006) Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 65(5):1375–1380

    PubMed  Google Scholar 

  • Kosmas C, Kallistratos MS, Kopterides P et al (2008) Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study. J Cancer Res Clin Oncol 134(1):75–82

    PubMed  CAS  Google Scholar 

  • Kutcher GJ, Burman C (1989) Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys 16(6):1623–1630

    PubMed  CAS  Google Scholar 

  • Labianca R, Beretta G, Clerici M et al (1982) Cardiac toxicity of 5-fluorouracil: a study on 1083 patients. Tumori 68(6):505–510

    PubMed  CAS  Google Scholar 

  • Lauk S, Kiszel Z, Buschmann J et al (1985) Radiation-induced heart disease in rats. Int J Radiat Oncol Biol Phys 11(4):801–808

    PubMed  CAS  Google Scholar 

  • Lee KF, Simon H, Chen H et al (1995a) Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378(6555):394–398

    PubMed  CAS  Google Scholar 

  • Lee SP, Leu MY, Smathers JB et al (1995b) Biologically effective dose distribution based on the linear quadratic model and its clinical relevance. Int J Radiat Oncol Biol Phys 33(2):375–389

    PubMed  CAS  Google Scholar 

  • Lee CK, Aeppli D, Nierengarten ME (2000) The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin’s disease: university of Minnesota experience. Int J Radiat Oncol Biol Phys 48(1):169–179

    PubMed  CAS  Google Scholar 

  • Lejemtel TH, Sonnenblick EH, Frishman WH (2004) Diagnosis and management of heart failure. In: Fuster V, Alexander RW, ‘O’Rourke RA (eds) Hurst’s the heart. McGraw-Hill, New York, pp 723–762

    Google Scholar 

  • Leonard RC, Williams S, Tulpule A et al (2009) Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet). Breast 18(4):218–224

    PubMed  CAS  Google Scholar 

  • Lind PA, Pagnanelli R, Marks LB et al (2003) Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. Int J Radiat Oncol Biol Phys 55(4):914–920

    PubMed  Google Scholar 

  • Ling LH, Oh JK, Schaff HV et al (1999) Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation 100(13):1380–1386

    PubMed  CAS  Google Scholar 

  • Lipshultz SE, Adams MJ (2010) Cardiotoxicity after childhood cancer: beginning with the end in mind. J Clin Oncol 28(8):1276–1281

    PubMed  Google Scholar 

  • Lipshultz SE, Sallan SE (1993) Cardiovascular abnormalities in long-term survivors of childhood malignancy. J Clin Oncol 11(7):1199–1203

    PubMed  CAS  Google Scholar 

  • Lipshultz SE, Colan SD, Gelber RD et al (1991) Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324(12):808–815

    PubMed  CAS  Google Scholar 

  • Lipshultz SE, Lipsitz SR, Mone SM et al (1995) Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 332(26):1738–1743

    PubMed  CAS  Google Scholar 

  • Lipshultz SE, Grenier MA, Colan SD (1999) Doxorubicin-induced cardiomyopathy. N Engl J Med 340(8):653–654

    PubMed  CAS  Google Scholar 

  • Lipshultz SE, Giantris AL, Lipsitz SR et al (2002) Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91–01 acute lymphoblastic leukemia protocol. J Clin Oncol 20(6):1677–1682

    PubMed  CAS  Google Scholar 

  • Lipshultz SE, Rifai N, Dalton VM et al (2004) The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med 351(2):145–153

    PubMed  CAS  Google Scholar 

  • Lipshultz SE, Alvarez JA, Scully RE (2008) Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart 94(4):525–533

    PubMed  CAS  Google Scholar 

  • Little MP (2009) Cancer and non-cancer effects in Japanese atomic bomb survivors. J Radiol Prot 29(2A):A43–A59

    Google Scholar 

  • Little MP (2010) Exposure to radiation and higher risk of circulatory disease. BMJ 340:b4326

    PubMed  Google Scholar 

  • Little MP, Tawn EJ, Tzoulaki I et al (2010) Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms. Radiat Environ Biophys 49(2):139–153

    PubMed  CAS  PubMed Central  Google Scholar 

  • Lu HM, Cash E, Chen MH et al (2000) Reduction of cardiac volume in left-breast treatment fields by respiratory maneuvers: a CT study. Int J Radiat Oncol Biol Phys 47(4):895–904

    PubMed  CAS  Google Scholar 

  • Lu L, Payvandi F, Wu L et al (2009) The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions. Microvasc Res 77(2):78–86

    PubMed  CAS  Google Scholar 

  • Lund MB, Ihlen H, Voss BM et al (1996) Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin’s disease: an echocardiographic study. Heart 75(6):591–595

    PubMed  CAS  PubMed Central  Google Scholar 

  • Luwaert RJ, Descamps O, Majois F et al (1991) Coronary artery spasm induced by 5-fluorouracil. Eur Heart J 12(3):468–470

    PubMed  CAS  Google Scholar 

  • Lyman JT (1985) Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 8:S13–S19

    PubMed  CAS  Google Scholar 

  • Maitland ML, Bakris GL, Black HR et al (2010) Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors. J Natl Cancer Inst 102(9):596–604

    PubMed  CAS  PubMed Central  Google Scholar 

  • Majhail NS, Flowers ME, Ness KK et al (2009) High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 43(1):49–54

    PubMed  CAS  PubMed Central  Google Scholar 

  • Manojlovic N, Babic D, Stojanovic S et al (2008) Capecitabine cardiotoxicity—case reports and literature review. Hepatogastroenterology 55(85):1249–1256

    PubMed  Google Scholar 

  • Marks LB, Yu X, Prosnitz RG et al (2005) The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys 63(1):214–223

    PubMed  Google Scholar 

  • Martel MK, Sahijdak WM, Ten Haken RK et al (1998) Fraction size and dose parameters related to the incidence of pericardial effusions. Int J Radiat Oncol Biol Phys 40(1):155–161

    PubMed  CAS  Google Scholar 

  • Martin M, Pienkowski T, Mackey J et al (2005) Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 352(22):2302–2313

    PubMed  CAS  Google Scholar 

  • Marty M, Cognetti F, Maraninchi D et al (2005) Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. J Clin Oncol 23(19):4265–4274

    PubMed  CAS  Google Scholar 

  • Matsumura T, Wolff K, Petzelbauer P (1997) Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J Immunol 158(7):3408–3416

    PubMed  CAS  Google Scholar 

  • McArthur HL, Chia S (2007) Cardiotoxicity of trastuzumab in clinical practice. N Engl J Med 357(1):94–95

    PubMed  CAS  Google Scholar 

  • McCray R, Francis GS, Fuster V (2009) Diagnosis and Management of Heart Failure. In: O’Rourke R, Walsh R, Fuster V (eds)

    Google Scholar 

  • McGuire WP, Rowinsky EK, Rosenshein NB et al (1989) Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 111(4):273–279

    PubMed  CAS  Google Scholar 

  • Meyer CC, Calis KA, Burke LB et al (1997) Symptomatic cardiotoxicity associated with 5-fluorouracil. Pharmacotherapy 17(4):729–736

    PubMed  CAS  Google Scholar 

  • Miller KD, Chap LI, Holmes FA et al (2005) Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. J Clin Oncol 23(4):792–799

    PubMed  CAS  Google Scholar 

  • Miller K, Wang M, Gralow J et al (2007) Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med 357(26):2666–2676

    PubMed  CAS  Google Scholar 

  • Minotti G, Menna P, Salvatorelli E et al (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56(2):185–229

    PubMed  CAS  Google Scholar 

  • Miura K, Daviglus ML, Dyer AR et al (2001) Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago heart association detection project in industry. Arch Intern Med 161(12):1501–1508

    PubMed  CAS  Google Scholar 

  • Morandi P, Ruffini PA, Benvenuto GM et al (2005) Cardiac toxicity of high-dose chemotherapy. Bone Marrow Transplant 35(4):323–334

    PubMed  CAS  Google Scholar 

  • Morton DL, Glancy DL, Joseph WL et al (1973) Management of patients with radiation-induced pericarditis with effusion: a note on the development of aortic regurgitation in two of them. Chest 64(3):291–297

    PubMed  CAS  Google Scholar 

  • Mosca L, Banka CL, Benjamin EJ et al (2007) Evidence-based guidelines for cardiovascular disease prevention in women: 2007 Update. J Am Coll Cardiol 49:1230–1250

    PubMed  Google Scholar 

  • Moser EC, Noordijk EM, van Leeuwen FE et al (2006) Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. Blood 107(7):2912–2919

    PubMed  CAS  Google Scholar 

  • Motzer RJ, Michaelson MD, Redman BG et al (2006a) Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 24(1):16–24

    Google Scholar 

  • Motzer RJ, Rini BI, Bukowski RM et al (2006b) Sunitinib in patients with metastatic renal cell carcinoma. JAMA 295(21):2516–2524

    Google Scholar 

  • Motzer RJ, Hutson TE, Tomczak P et al (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356(2):115–124

    PubMed  CAS  Google Scholar 

  • Mulrooney DA, Yeazel MW, Kawashima T et al (2009) Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the childhood cancer survivor study cohort. BMJ 339:b4606

    PubMed  PubMed Central  Google Scholar 

  • Myrehaug S, Pintilie M, Tsang R et al (2008) Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapy. Leuk Lymphoma 49(8):1486–1493

    PubMed  CAS  Google Scholar 

  • Myrehaug S, Pintilie M, Yun L et al (2010) A population-based study of cardiac morbidity among Hodgkin lymphoma patients with pre-existing heart disease. Blood 116:2237–2240

    Google Scholar 

  • Ng M, Cunningham D, Norman AR (2005) The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC). Eur J Cancer 41(11):1542–1546

    PubMed  CAS  Google Scholar 

  • Noori A, Lindenfeld J, Wolfel E et al (2000) Beta-blockade in adriamycin-induced cardiomyopathy. J Cardiac Fail 6(2):115–119

    CAS  Google Scholar 

  • Nuver J, Smit AJ, van der Meer J et al (2005) Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol 23(36):9130–9137

    PubMed  CAS  Google Scholar 

  • Ohnishi K, Yoshida H, Shigeno K et al (2002) Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring. Leukemia 16(4):617–622

    PubMed  CAS  Google Scholar 

  • Olsen EA, Kim YH, Kuzel TM et al (2007) Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma. J Clin Oncol 25(21):3109–3115

    PubMed  CAS  Google Scholar 

  • Ozcelik C, Erdmann B, Pilz B et al (2002) Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy. Proc Natl Acad Sci U S A 99(13):8880–8885

    PubMed  CAS  PubMed Central  Google Scholar 

  • Pai VB, Nahata MC (2000) Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf 22(4):263–302

    PubMed  CAS  Google Scholar 

  • Pakala R, Leborgne L, Cheneau E et al (2003) Radiation-induced atherosclerotic plaque progression in a hypercholesterolemic rabbit: a prospective vulnerable plaque model? Cardiovasc Radiat Med 4(3):146–151

    PubMed  Google Scholar 

  • Palazzuoli A, Gallotta M, Quatrini I et al (2010) Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vasc Health Risk Manag 6:411–418

    PubMed  CAS  PubMed Central  Google Scholar 

  • Pande A, Lombardo J, Spangenthal E et al (2007) Hypertension secondary to anti-angiogenic therapy: experience with bevacizumab. Anticancer Res 27(5B):3465–3470

    Google Scholar 

  • Paszat LF, Mackillop WJ, Groome PA et al (1998) Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol 16(8):2625–2631

    PubMed  CAS  Google Scholar 

  • Patel DA, Kochanski J, Suen AW et al (2006) Clinical manifestations of noncoronary atherosclerotic vascular disease after moderate dose irradiation. Cancer 106(3):718–725

    PubMed  Google Scholar 

  • Perez EA, Suman VJ, Davidson NE et al (2008a) Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the north central cancer treatment group N9831 adjuvant breast cancer trial. J Clin Oncol 26(8):1231–1238

    Google Scholar 

  • Perez EA, Koehler M, Byrne J et al (2008b) Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials. Mayo Clin Proc 83(6):679–686

    Google Scholar 

  • Piedbois P, Becquemin JP, Blanc I et al (1990) Arterial occlusive disease after radiotherapy: a report of fourteen cases. Radiother Oncol 17(2):133–140

    PubMed  CAS  Google Scholar 

  • Piovaccari G, Ferretti RM, Prati F et al (1995) Cardiac disease after chest irradiation for Hodgkin’s disease: incidence in 108 patients with long follow-up. Int J Cardiol 49(1):39–43

    PubMed  CAS  Google Scholar 

  • Preston DL, Shimizu Y, Pierce DA et al (2003) Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950–1997. Radiat Res 160(4):381–407

    PubMed  CAS  Google Scholar 

  • Quezado ZM, Wilson WH, Cunnion RE et al (1993) High-dose ifosfamide is associated with severe, reversible cardiac dysfunction. Ann Intern Med 118(1):31–36

    PubMed  CAS  Google Scholar 

  • Reinders JG, Heijmen BJ, Olofsen-van Acht MJ et al (1999) Ischemic heart disease after mantlefield irradiation for Hodgkin’s disease in long-term follow-up. Radiother Oncol 51(1):35–42

    Google Scholar 

  • Rezkalla S, Kloner RA, Ensley J et al (1989) Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study. J Clin Oncol 7(4):509–514

    PubMed  CAS  Google Scholar 

  • Robben NC, Pippas AW, Moore JO (1993) The syndrome of 5-fluorouracil cardiotoxicity. An elusive cardiopathy. Cancer 71(2):493–509

    PubMed  CAS  Google Scholar 

  • Rodeghiero F, Elice F (2003) Thalidomide and thrombosis. Pathophysiol Haemost Thromb 33(Suppl 1):15–18

    PubMed  Google Scholar 

  • Romond EH, Perez EA, Bryant J et al (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353(16):1673–1684

    PubMed  CAS  Google Scholar 

  • Rose G, Baxter PJ, Reid DD et al (1978) Prevalence and prognosis of electrocardiographic findings in middle-aged men. Br Heart J 40(6):636–643

    PubMed  CAS  PubMed Central  Google Scholar 

  • Rowinsky EK, McGuire WP, Guarnieri T et al (1991) Cardiac disturbances during the administration of taxol. J Clin Oncol 9(9):1704–1712

    PubMed  CAS  Google Scholar 

  • Rubin P, Casarett GW (1968) Clinical Radiation Pathology. Philadelphia, WB Saunders

    Google Scholar 

  • Rutqvist LE, Johansson H (1990) Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish cancer registry. Br J Cancer 61(6):866–868

    PubMed  CAS  PubMed Central  Google Scholar 

  • Saif MW, Tomita M, Ledbetter L et al (2008) Capecitabine-related cardiotoxicity: recognition and management. J Support Oncol 6(1):41–48

    PubMed  CAS  Google Scholar 

  • Sasson Z, Morgan CD, Wang B et al (1994) 5-Fluorouracil related toxic myocarditis: case reports and pathological confirmation. Can J Cardiol 10(8):861–864

    PubMed  CAS  Google Scholar 

  • Scappaticci FA, Skillings JR, Holden SN et al (2007) Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst 99(16):1232–1239

    PubMed  Google Scholar 

  • Schnetzler B, Popova N, Collao LC et al (2001) Coronary spasm induced by capecitabine. Ann Oncol 12(5):723–724

    PubMed  CAS  Google Scholar 

  • Schober C, Papageorgiou E, Harstrick A et al (1993) Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer. Cancer 72(7):2242–2247

    PubMed  CAS  Google Scholar 

  • Schomig K, Ndrepepa G, Mehilli J et al (2007) Thoracic radiotherapy in patients with lymphoma and restenosis after coronary stent placement. Catheter Cardiovasc Interv 70(3):359–365

    PubMed  Google Scholar 

  • Schultz-Hector S (1992) Radiation-induced heart disease: review of experimental data on dose response and pathogenesis. Int J Radiat Biol 61(2):149–160

    PubMed  CAS  Google Scholar 

  • Schultz-Hector S, Trott KR (2007) Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data? Int J Radiat Oncol Biol Phys 67(1):10–18

    PubMed  CAS  Google Scholar 

  • Scott AS, Parr LA, Johnstone PA (2009) Risk of cerebrovascular events after neck and supraclavicular radiotherapy: a systematic review. Radiother Oncol 90(2):163–165

    PubMed  Google Scholar 

  • Seddon B, Cook A, Gothard L et al (2002) Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy. Radiother Oncol 64(1):53–63

    PubMed  Google Scholar 

  • Seidman A, Hudis C, Pierri MK et al (2002) Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 20(5):1215–1221

    PubMed  CAS  Google Scholar 

  • Senkus-Konefka E, Jassem J (2007) Cardiovascular effects of breast cancer radiotherapy. Cancer Treat Rev 33(6):578–593

    PubMed  Google Scholar 

  • Sereno M, Brunello A, Chiappori A et al (2008) Cardiac toxicity: old and new issues in anti-cancer drugs. Clin Transl Oncol 10(1):35–46

    PubMed  CAS  Google Scholar 

  • Shapiro CL, Hardenbergh PH, Gelman R et al (1998) Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol 16(11):3493–3501

    PubMed  CAS  Google Scholar 

  • Shigeno K, Naito K, Sahara N et al (2005) Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies. Int J Hematol 82(3):224–229

    PubMed  CAS  Google Scholar 

  • Shimizu Y, Pierce DA, Preston DL et al (1999) Studies of the mortality of atomic bomb survivors. Report 12, part II. noncancer mortality: 1950–1990. Radiat Res 152(4):374–389

    PubMed  CAS  Google Scholar 

  • Shiojima I, Sato K, Izumiya Y et al (2005) Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115(8):2108–2118

    PubMed  CAS  PubMed Central  Google Scholar 

  • Shoemaker LK, Arora U (2004) Rocha Lima CM. 5-fluorouracil-induced coronary vasospasm. Cancer Control 11(1):46–49

    PubMed  Google Scholar 

  • Singal PK, Iliskovic N (1998) Doxorubicin-induced cardiomyopathy. N Engl J Med 339(13):900–905

    PubMed  CAS  Google Scholar 

  • Singer JW (2001) Cardiac toxicity of arsenic trioxide. Blood 98(5):1633–1634

    PubMed  CAS  Google Scholar 

  • Slamon DJ, Leyland-Jones B, Shak S et al (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344(11):783–792

    PubMed  CAS  Google Scholar 

  • Soignet SL, Frankel SR, Douer D et al (2001) United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 19(18):3852–3860

    PubMed  CAS  Google Scholar 

  • Sorensen K, Levitt G, Sebag-Montefiore D et al (1995) Cardiac function in Wilms’ tumor survivors. J Clin Oncol 13(7):1546–1556

    PubMed  CAS  Google Scholar 

  • Spector NL, Yarden Y, Smith B et al (2007) Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells. Proc Natl Acad Sci U S A 104(25):10607–10612

    PubMed  CAS  PubMed Central  Google Scholar 

  • Stewart JR, Fajardo LF, Gillette SM et al (1995) Radiation injury to the heart. Int J Radiat Oncol Biol Phys 31(5):1205–1211

    PubMed  CAS  Google Scholar 

  • Stewart FA, Heeneman S, Te PJ et al (2006) Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am J Pathol 168(2):649–658

    PubMed  CAS  PubMed Central  Google Scholar 

  • Stewart FA, Hoving S, Russell NS (2010) Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients. Radiat Res 174(6):865–869

    PubMed  CAS  Google Scholar 

  • Stickeler E, Klar M, Watermann D et al (2009) Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial. Breast Cancer Res Treat 117(3):591–598

    PubMed  CAS  Google Scholar 

  • Strasser F, Betticher DC, Suter TM (2001) Trastuzumab and breast cancer. N Engl J Med 345(13):996

    PubMed  CAS  Google Scholar 

  • Subgroup on Circulatory Disease Risk of the Advisory Group on Ionising Radiation (2010) Circulatory Disease Risk RCE 16, Chilton, pp 1–130 (in press) Ref Type: Report http://www.icrp.org/page.asp?id=116

  • Sudhoff T, Enderle MD, Pahlke M et al (2004) 5-Fluorouracil induces arterial vasocontractions. Ann Oncol 15(4):661–664

    PubMed  CAS  Google Scholar 

  • Suter TM, Procter M, van Veldhuisen DJ et al (2007) Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. J Clin Oncol 25(25):3859–3865

    PubMed  CAS  Google Scholar 

  • Swain SM, Whaley FS, Gerber MC et al (1997) Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer. J Clin Oncol 15(4):1318–1332

    PubMed  CAS  Google Scholar 

  • Swerdlow AJ, Higgins CD, Smith P et al (2007) Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst 99(3):206–214

    PubMed  Google Scholar 

  • Talreja DR, Edwards WD, Danielson GK et al (2003) Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation 108(15):1852–1857

    PubMed  Google Scholar 

  • Tan-Chiu E, Yothers G, Romond E et al (2005) Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31. J Clin Oncol 23(31):7811–7819

    PubMed  CAS  Google Scholar 

  • Taylor CW, McGale P, Darby SC (2006) Cardiac risks of breast-cancer radiotherapy: a contemporary view. Clin Oncol (R Coll Radiol) 18(3):236–246

    CAS  Google Scholar 

  • Tillman B (2007) Atlas of Human Anatomy, Mud Puddle Books Inc, New York, pp 224

    Google Scholar 

  • Tirilomis T, Unverdorben S, von der Emde J (1994) Pericardectomy for chronic constrictive pericarditis: risks and outcome. Eur J Cardiothorac Surg 8(9):487–492

    Google Scholar 

  • Tribble DL, Barcellos-Hoff MH, Chu BM et al (1999) Ionizing radiation accelerates aortic lesion formation in fat-fed mice via SOD-inhibitable processes. Arterioscler Thromb Vasc Biol 19(6):1387–1392

    PubMed  CAS  Google Scholar 

  • Tripathy D, Slamon DJ, Cobleigh M et al (2004) Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression. J Clin Oncol 22(6):1063–1070

    PubMed  CAS  Google Scholar 

  • Trudeau ME, Clemons MJ, Provencher L et al (2009) Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines. J Clin Oncol 27(35):5906–5910

    PubMed  CAS  Google Scholar 

  • Tsavaris N, Kosmas C, Vadiaka M et al (2002) Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy—a survey of 427 patients. Med Sci Monit 8(6):I51–I57

    Google Scholar 

  • Tsibiribi P, Descotes J, Lombard-Bohas C et al (2006a) Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease. Bull Cancer 93(3):E27–E30

    PubMed  Google Scholar 

  • Tsibiribi P, Bui-Xuan C, Bui-Xuan B et al (2006b) Cardiac lesions induced by 5-fluorouracil in the rabbit. Hum Exp Toxicol 25(6):305–309

    PubMed  CAS  Google Scholar 

  • Tukenova M, Guibout C, Oberlin O et al (2010) Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol 28(8):1308–1315

    PubMed  Google Scholar 

  • Unnikrishnan D, Dutcher JP, Garl S et al (2004) Cardiac monitoring of patients receiving arsenic trioxide therapy. Br J Haematol 124(5):610–617

    PubMed  Google Scholar 

  • Van Cutsem E, Hoff PM, Blum JL et al (2002) Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil. Ann Oncol 13(3):484–485

    PubMed  Google Scholar 

  • Van Dalen EC, Caron HN, Dickinson HO et al (2008) Cardioprotective interventions for cancer patients receiving anthracyclines. Cochrane Database Syst Rev 2:CD003917

    Google Scholar 

  • Van Dalen EC, van der Pal HJ, Caron HN et al (2009) Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy. Cochrane Database Syst Rev 4:CD005008

    Google Scholar 

  • Van Heeckeren WJ, Sanborn SL, Narayan A et al (2007) Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis. Curr Opin Hematol 14(5):468–480

    PubMed  Google Scholar 

  • Van Kuilenburg AB, Meinsma R, Zoetekouw L et al (2002) Increased risk of grade IV neutropenia after administration of 5-fluorouracil due to a dihydropyrimidine dehydrogenase deficiency: high prevalence of the IVS14 + 1 g > a mutation. Int J Cancer 101(3):253–258

    PubMed  Google Scholar 

  • Van Luijk P, Faber H, Meertens H et al (2007) The impact of heart irradiation on dose-volume effects in the rat lung. Int J Radiat Oncol Biol Phys 69(2):552–559

    Google Scholar 

  • Veinot JP, Edwards WD (1996) Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol 27(8):766–773

    PubMed  CAS  Google Scholar 

  • Verheij M, Dewit LG, Valdes Olmos RA et al (1994) Evidence for a renovascular component in hypertensive patients with late radiation nephropathy. Int J Radiat Oncol Biol Phys 30(3):677–683

    Google Scholar 

  • Vermorken JB, Remenar E, van Herpen C et al (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357(17):1695–1704

    Google Scholar 

  • Vogel CL, Cobleigh MA, Tripathy D et al (2002) Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 20(3):719–726

    PubMed  CAS  Google Scholar 

  • Von Hoff DD, Layard MW, Basa P et al (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91(5):710–717

    Google Scholar 

  • Voortman J, Giaccone G (2006) Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report. BMC Cancer 6:129

    PubMed  PubMed Central  Google Scholar 

  • Vorchheimer DA (2005) What is QT interval prolongation? J Fam Pract Suppl:S4–S7

    Google Scholar 

  • Vos J, Aarnoudse MW, Dijk F et al (1983) On the cellular origin and development of atheromatous plaques. A light and electron microscopic study of combined X-ray and hypercholesterolemia-induced atheromatosis in the carotid artery of the rabbit. Virchows Arch B Cell Pathol Incl Mol Pathol 43(1):1–16

    PubMed  CAS  Google Scholar 

  • Wacker A, Lersch C, Scherpinski U et al (2003) High incidence of angina pectoris in patients treated with 5-fluorouracil. A planned surveillance study with 102 patients. Oncology 65(2):108–112

    PubMed  CAS  Google Scholar 

  • Walko CM, Lindley C (2005) Capecitabine: a review. Clin Ther 27(1):23–44

    PubMed  CAS  Google Scholar 

  • Wei X, Liu HH, Tucker SL et al (2008) Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys 70(3):707–714

    PubMed  Google Scholar 

  • Westervelt P, Brown RA, Adkins DR et al (2001) Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood 98(2):266–271

    PubMed  CAS  Google Scholar 

  • Wethal T, Kjekshus J, Roislien J et al (2007) Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer. J Cancer Surviv 1(1):8–16

    PubMed  CAS  Google Scholar 

  • Wethal T, Lund MB, Edvardsen T et al (2009) Valvular dysfunction and left ventricular changes in Hodgkin’s lymphoma survivors. A longitudinal study. Br J Cancer 101(4):575–581

    PubMed  CAS  PubMed Central  Google Scholar 

  • Wojnowski L, Kulle B, Schirmer M et al (2005) NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation 112(24):3754–3762

    PubMed  CAS  Google Scholar 

  • Wong FL, Yamada M, Sasaki H et al (1993) Noncancer disease incidence in the atomic bomb survivors: 1958–1986. Radiat Res 135(3):418–430

    PubMed  CAS  Google Scholar 

  • Wouters KA, Kremer LC, Miller TL et al (2005) Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies. Br J Haematol 131(5):561–578

    PubMed  CAS  Google Scholar 

  • Wu S, Chen JJ, Kudelka A et al (2008) Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis. Lancet Oncol 9(2):117–123

    PubMed  CAS  Google Scholar 

  • Yamaguchi O, Watanabe T, Nishida K et al (2004) Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis. J Clin Invest 114(7):937–943

    PubMed  CAS  PubMed Central  Google Scholar 

  • Yang JC, Haworth L, Sherry RM et al (2003) A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 349(5):427–434

    PubMed  CAS  PubMed Central  Google Scholar 

  • Yeh ET, Bickford CL (2009) Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol 53(24):2231–2247

    PubMed  CAS  Google Scholar 

  • Yeh ET, Tong AT, Lenihan DJ et al (2004) Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109(25):3122–3131

    PubMed  Google Scholar 

  • Yusuf S, Hawken S, Ounpuu S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937–952

    PubMed  Google Scholar 

  • Zangari M, Elice F, Fink L et al (2007) Thrombosis in multiple myeloma. Expert Rev Anticancer Ther 7(3):307–315

    PubMed  CAS  Google Scholar 

  • Zhao YY, Sawyer DR, Baliga RR et al (1998) Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem 273(17):10261–10269

    PubMed  CAS  Google Scholar 

  • Zuppinger C, Timolati F, Suter TM (2007) Pathophysiology and diagnosis of cancer drug induced cardiomyopathy. Cardiovasc Toxicol 7(2):61–66

    PubMed  CAS  Google Scholar 

Recommended Reading

  • Lipshultz, SE, Alvarez JA, Scully RE (2008) Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart 94(4):525–533

    Google Scholar 

  • Chen MH, Kerkela R, Force T (2008) Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics. Circulation 118(1):84–95

    Google Scholar 

  • Lipshultz SE, Adams MJ (2010) Cardiotoxicity after childhood cancer: beginning with the end in mind. J Clin Oncol 28(8):1276–1281

    Google Scholar 

  • Chen MH, Colan SD, and Diller LD (2011) Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers. Circ Res 108:619–628

    Google Scholar 

  • Adams MJ, Lipshultz SE (2005) Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: Implications for screening and prevention. Pediatr Blood Cancer 44(7):600–606

    Google Scholar 

  • Schultz-Hector S, Trott KR (2007) Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data? Int J Radiat Oncol Biol Phys 67(1):10–18

    Google Scholar 

  • Gagliardi G, Constine LS, Moiseenko V, Correa C, Pierce LJ, Allen AM et al (2010) Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 76(3 Suppl):S77–S85

    Google Scholar 

  • Darby SC, Cutter DJ, Boerma M, Constine LS, Fajardo LF, Kodama K et al (2010) Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys 76(3):656–665

    Google Scholar 

  • De Haas EC, Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, Gietema JA (2010) The metabolic syndrome in cancer survivors. Lancet Oncol 11(2):193–203

    Google Scholar 

  • Albini A, Pennesi G, Donatelli F, Cammarota R, De FS, Noonan DM (2010) Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst 102(1):14–25

    Google Scholar 

  • ACC/AHA guidelines on treatment of heart failure

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiotherapy, The Netherlands Cancer Institue, Amsterdam, The Netherlands

    Berthe M. P. Aleman

  2. Department of Oncology and Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

    Lena Specht

  3. Children’s Hospital Boston and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

    Ming Hui Chen

Authors
  1. Berthe M. P. Aleman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lena Specht
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ming Hui Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Berthe M. P. Aleman .

Editor information

Editors and Affiliations

  1. Dept. Radiation Oncology, University of Rochester Medical Center James P. Wilmot Cancer Ctr., Rochester, New York, USA

    Philip Rubin

  2. Department of Radiation Oncology, University of Rochester Medical Center James P. Wilmot Cancer Ctr., Rochester, New York, USA

    Louis S. Constine

  3. Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina, USA

    Lawrence B. Marks

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Aleman, B.M.P., Specht, L., Chen, M.H. (2014). Heart, Coronary Arteries, Aorta and Great Vessels, Arteries and Veins, Microcirculation. In: Rubin, P., Constine, L., Marks, L. (eds) ALERT • Adverse Late Effects of Cancer Treatment. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75863-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-75863-1_12

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-75862-4

  • Online ISBN: 978-3-540-75863-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation